Comments
Loading...

INmune Bio

INMBNASDAQ
Logo brought to you by Benzinga Data
$7.67
1.1417.55%
At close: -
$7.80
0.131.69%
After Hours: 4:25 PM EDT

INmune Bio (NASDAQ:INMB) Stock, Earnings Estimates, EPS, And Revenue

INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 27
EPS Estimate
$-0.560
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)
$42.00K

Analyze the earnings history of INmune Bio using advanced sorting and filters.

Data brought to you by Benzinga APIs

INmune Bio (INMB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-10-31$-0.60$-0.50-20.0 %
Q22024-08-01$-0.50$-0.6320.6 %
Q12024-05-09$-0.61$-0.53-15.1 %
Q42024-03-28$-0.47$-0.44-6.82 %

INmune Bio (INMB) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q12024-05-09$14.00K$30.00K-53.3 %
Q42024-03-28$28.00K$40.00K-30.0 %
Q32021-11-03$14.00K$970.00K-98.6 %

FAQ

Q

When is INmune Bio (NASDAQ:INMB) reporting earnings?

A

INmune Bio (INMB) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?

A

The Actual EPS was $-0.60, which missed the estimate of $-0.50.

Q

What were INmune Bio’s (NASDAQ:INMB) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch